Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules. (Q40673821)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

title

Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Iuri Marinov

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

author name string

Pavel Síma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Viera Ludvíková

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Dana Pokorná

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Vladimír Vonka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

language of work or name

English

0 references

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

issue

11-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

page(s)

1125-1136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

Behavior of mild cervical dysplasia during long-term follow-up

17 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Developing HPV virus-like particle vaccines to prevent cervical cancer: a progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Immunization against human papillomavirus infection and associated neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Human papillomavirus genotype 16 vaccines for cervical cancer prophylaxis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Evaluation of multiple biologic parameters in cervical carcinoma: high macrophage infiltration in HPV-associated tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

HLA class I expression on human cancer cells. Implications for effective immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Antigen-processing machinery breakdown and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Identification of human cancers deficient in antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Molecular characterization of defective antigen processing in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

LMP-associated proteolytic activities and TAP-dependent peptide transport for class 1 MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Tumor Heterogeneity and Immunotherapy of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Chimeric papillomavirus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Analysis of human papillomavirus type 16 E6-E7 transcription in cervical carcinomas and normal cervical epithelium using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Interferon gamma regulates HLA-D expression on solid tumors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Recombinant gamma interferon induces HLA-DR expression on squamous cell carcinoma, trichilemmoma, adenocarcinoma cell lines, and cultured human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Induction of HLA-DR antigen on human squamous carcinoma by recombinant interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Analysis of HLA-DR expression on keratinocytes in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

NK cells modulate MHC class I expression on tumor cells and their susceptibility to lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Antigenic Changes in Cultured Murine Lymphomas After Retransplantation Into Syngeneic Hosts2

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

An active T-cell-independent mechanism enhances MHC class I transcription and expression on a mouse T-cell lymphoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

The role of CD4+ T cell responses in antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Administration of subtumor regression dosage of TNF-alpha to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900519-4

7 January 2021

10.1016/S0264-410X(02)00519-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559790%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference